FDA
-
-
-
-
-
-
-
Endocyte (ECYT) Reports FDA Acceptance of Radiographic Progression Free Survival as Alternative Primary Endpoint of VISION Trial
-
-
-
-
-
-
-
Endocyte Provides First Quarter 2018 Financial Results and Operational Update
-
-
-
-
-
-
-
Endocyte Reports Third Quarter Financial Results
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

